Doubly Robust Inference for Hazard Ratio under Informative Censoring with Machine Learning
Jiyu Luo, Ronghui Xu

TL;DR
This paper introduces a new doubly robust estimator for hazard ratios in clinical trials with informative censoring, leveraging machine learning to improve inference under model misspecification.
Contribution
It develops an augmented IPCW estimator with doubly robust properties that combine machine learning models for failure and censoring times, ensuring valid inference.
Findings
The estimator is consistent and asymptotically normal if either model is correctly specified.
It is rate doubly robust, requiring the product of estimation errors to be faster than root-n.
Simulation studies demonstrate its finite-sample performance.
Abstract
Randomized clinical trials with time-to-event outcomes have traditionally used the log-rank test followed by the Cox proportional hazards (PH) model to estimate the hazard ratio between the treatment groups. These are valid under the assumption that the right-censoring mechanism is non-informative, i.e. independent of the time-to-event of interest within each treatment group. More generally, the censoring time might depend on additional covariates, and inverse probability of censoring weighting (IPCW) can be used to correct for the bias resulting from the informative censoring. IPCW requires a correctly specified censoring time model conditional on the treatment and the covariates. Doubly robust inference in this setting has not been plausible previously due to the non-collapsibility of the Cox model. However, with the recent development of data-adaptive machine learning methods we…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods and Inference · Advanced Causal Inference Techniques · Statistical Methods in Clinical Trials
